-
1
-
-
0026595134
-
Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia
-
Wandl UB, Kloke O, Nidierle N. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia. Lancet. 339:1992;123-124.
-
(1992)
Lancet
, vol.339
, pp. 123-124
-
-
Wandl, U.B.1
Kloke, O.2
Nidierle, N.3
-
2
-
-
0025936628
-
Liver failure due to recombinant alpha interferon
-
Durand JM, Kaplanski G, Portal I, Scheiner C, Berland Y, Soubeyrand J. Liver failure due to recombinant alpha interferon. Lancet. 338:1991;1268-1269.
-
(1991)
Lancet
, vol.338
, pp. 1268-1269
-
-
Durand, J.M.1
Kaplanski, G.2
Portal, I.3
Scheiner, C.4
Berland, Y.5
Soubeyrand, J.6
-
3
-
-
0027255306
-
Liver damage during interferon therapy for chronic myeloid leukaemia
-
Philippe P, Fialip J, Souweine B, Aumaitre O, Marcheix JC, Lavarenne J. Liver damage during interferon therapy for chronic myeloid leukaemia. Eur J Med. 2:1993;446.
-
(1993)
Eur J Med
, vol.2
, pp. 446
-
-
Philippe, P.1
Fialip, J.2
Souweine, B.3
Aumaitre, O.4
Marcheix, J.C.5
Lavarenne, J.6
-
4
-
-
0030923160
-
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C
-
Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C. Ann Intern Med. 126:1997;874-881.
-
(1997)
Ann Intern Med
, vol.126
, pp. 874-881
-
-
Martinot, M.1
Marcellin, P.2
Boyer, N.3
Detmer, J.4
Pouteau, M.5
Castelnau, C.6
-
5
-
-
0027402590
-
Fatal hepatic decompensation associated with interferon alfa
-
Janssen HLA, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxi A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alfa. Br Med J. 306:1993;107-108.
-
(1993)
Br Med J
, vol.306
, pp. 107-108
-
-
Janssen, H.L.A.1
Brouwer, J.T.2
Nevens, F.3
Sanchez-Tapias, J.M.4
Craxi, A.5
Hadziyannis, S.6
-
6
-
-
0026603501
-
Acute exacerbations of liver disease during interferon alfa therapy for chronic hepatitis C
-
Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbations of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology. 102:1992;1406-1408.
-
(1992)
Gastroenterology
, vol.102
, pp. 1406-1408
-
-
Shindo, M.1
Di Bisceglie, A.M.2
Hoofnagle, J.H.3
-
7
-
-
0028146133
-
Recurrent clinical exacerbations of liver disease during the course of infection with hepatitis C virus
-
Yavorski RT, Smith MA, Sjogren MH, Wang RKH. Recurrent clinical exacerbations of liver disease during the course of infection with hepatitis C virus. Am J Gastroenterol. 89:1994;1235-1237.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 1235-1237
-
-
Yavorski, R.T.1
Smith, M.A.2
Sjogren, M.H.3
Wang, R.K.H.4
-
8
-
-
0028587185
-
Hepatic injury after interferon alfa therapy for chronic hepatitis C
-
Shimizu Y, Joho S, Watanabe A. Hepatic injury after interferon alfa therapy for chronic hepatitis C. Ann Intern Med. 121:1994;723.
-
(1994)
Ann Intern Med
, vol.121
, pp. 723
-
-
Shimizu, Y.1
Joho, S.2
Watanabe, A.3
-
10
-
-
0018352913
-
Interferon induced enzymatic activities and their role in antiviral state
-
Baglioni C. Interferon induced enzymatic activities and their role in antiviral state. Cell. 17:1979;255-264.
-
(1979)
Cell
, vol.17
, pp. 255-264
-
-
Baglioni, C.1
-
11
-
-
0026756261
-
Changes in ultrastructure of hepatocytes and liver tests results before, during, and after treatment with interferon-β In patients with HBeAg-positive chronic active hepatitis
-
Itoh S, Marutani K, Matsuo S. Changes in ultrastructure of hepatocytes and liver tests results before, during, and after treatment with interferon-β in patients with HBeAg-positive chronic active hepatitis. Dig Dis Sci. 37:1992;1260-1267.
-
(1992)
Dig Dis Sci
, vol.37
, pp. 1260-1267
-
-
Itoh, S.1
Marutani, K.2
Matsuo, S.3
-
12
-
-
0029127584
-
Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity
-
Fromenty B, Pessayre D. Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 67:1995;101-154.
-
(1995)
Pharmacol Ther
, vol.67
, pp. 101-154
-
-
Fromenty, B.1
Pessayre, D.2
-
13
-
-
0027222630
-
Biological basis for the clinical use of interferon
-
(suppl.)
-
Dianzani F. Biological basis for the clinical use of interferon. Gut. 34:1993;74-76. (suppl.).
-
(1993)
Gut
, vol.34
, pp. 74-76
-
-
Dianzani, F.1
-
14
-
-
0028230046
-
Hazard of interferon treatment in patients with autoimmune chronic active hepatitis
-
Farhat BA, Johnson PJ, Williams R. Hazard of interferon treatment in patients with autoimmune chronic active hepatitis. J Hepatol. 20:1994;560-561.
-
(1994)
J Hepatol
, vol.20
, pp. 560-561
-
-
Farhat, B.A.1
Johnson, P.J.2
Williams, R.3
-
15
-
-
0026580021
-
Autoimmune chronic hepatitis exarcerbated by alpha-interferon
-
Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exarcerbated by alpha-interferon. Ann Intern Med. 116:1992;51-53.
-
(1992)
Ann Intern Med
, vol.116
, pp. 51-53
-
-
Papo, T.1
Marcellin, P.2
Bernuau, J.3
Durand, F.4
Poynard, T.5
Benhamou, J.P.6
-
16
-
-
0028148193
-
Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C
-
Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 21:1994;199-203.
-
(1994)
J Hepatol
, vol.21
, pp. 199-203
-
-
Muratori, L.1
Lenzi, M.2
Cataleta, M.3
Giostra, F.4
Cassani, F.5
Ballardini, G.6
-
17
-
-
0026473508
-
Hepatite auto-immune de type 1, révélée par un traitement par interf'eron
-
Tran A, Beusnel C, Montoya ML, Lussiez V, Hebuterne X, Rampal P. Hepatite auto-immune de type 1, révélée par un traitement par interf'eron. Gastroenterol Clin Biol. 16:1992;722-723.
-
(1992)
Gastroenterol Clin Biol
, vol.16
, pp. 722-723
-
-
Tran, A.1
Beusnel, C.2
Montoya, M.L.3
Lussiez, V.4
Hebuterne, X.5
Rampal, P.6
-
18
-
-
0027276493
-
Révélation d'une hépatite auto-immune par l'interféron
-
Payen JL, Rabbia I, Combis JM, Voigt JJ, Vinel JP, Pascal JP. Révélation d'une hépatite auto-immune par l'interféron. Gastroenterol Clin Biol. 17:1993;404-405.
-
(1993)
Gastroenterol Clin Biol
, vol.17
, pp. 404-405
-
-
Payen, J.L.1
Rabbia, I.2
Combis, J.M.3
Voigt, J.J.4
Vinel, J.P.5
Pascal, J.P.6
-
19
-
-
0029045221
-
Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C
-
Garcia-Buey L, Garcia-Monzon C, Rodriguez S, Borque MJ, Garcia-Sanchez A, Iglesias R, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology. 108:1995;1770-1777.
-
(1995)
Gastroenterology
, vol.108
, pp. 1770-1777
-
-
Garcia-Buey, L.1
Garcia-Monzon, C.2
Rodriguez, S.3
Borque, M.J.4
Garcia-Sanchez, A.5
Iglesias, R.6
|